Combination of | |
---|---|
Mometasone furoate | Corticosteroid |
Formoterol fumarate | Long-acting β2 adrenoreceptor agonist (LABA) |
Clinical data | |
Trade names | Zenhale, Dulera, others |
AHFS/Drugs.com | Professional Drug Facts |
License data | |
Routes of administration | Inhalation (Metered-dose inhaler MDI) |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
KEGG | |
(what is this?) (verify) |
Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma.[1] It contains mometasone a steroid and formoterol a long-acting beta agonist.[1] It is only recommended in those for whom an inhaled steroid is not sufficient.[1] It is used by inhalation.[1]
Common side effect include headache and sinusitis.[1] More serious side effects may include thrush, immunosuppression, allergic reactions, and cataracts.[1] Use is not recommended in those less than twelve years of age.[1] It has not been studied during pregnancy or breastfeeding.[1] Mometasone works by decreasing inflammation while formoterol works by relaxing smooth muscle in the airways.[1]
The combination was approved for medical use in the United States in 2010.[1] No generic version is available as of 2019[update]. In 2021, it was the 215th most commonly prescribed medication in the United States, with more than 1 million prescriptions.[2][3] It is on the World Health Organization's List of Essential Medicines.[4]